Sign in Subscribe
Coronaviruses

Elevated miRNA Expression and IL-6 Levels in COVID-19 Patients: Correlations and Implications for Inflammatory Response

Strategic Insights

— 1 min read

A recent study conducted by researchers at Ahvaz Jundishapur University of Medical Sciences, in collaboration with international experts, has shed new light on the role of microRNAs (miRNAs) in the diagnosis and management of COVID-19. The study analyzed the expression levels of miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p in the blood samples of COVID-19 patients, along with the expression level of interleukin-6 (IL-6) as a biomarker. The research team found that all examined expression factors were markedly elevated in COVID-19 patients compared to the control group.

Key Takeaways:

  • The study included 60 COVID-19 patients confirmed by an infectious disease specialist and positive real-time PCR tests, hospitalized at Razi Hospital, Ahvaz, and 30 healthy individuals as the control group.
  • The researchers observed significant elevations in the expression levels of miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p in COVID-19 patients compared to the control group.
  • IL-6 levels were found to be significantly elevated in COVID-19 patients, with a correlation observed between IL-6 levels and miRNA expression profiles.
  • The study suggests that miRNA and IL-6 expression profiles could be instrumental in the diagnosis and management of COVID-19, providing new avenues for therapeutic interventions and improving patient outcomes.
  • Authors of the study include Niloofar Neisi, Zahra Abolfath Beigi, Mehdi Parsanahad, Roya Pirmoradi, and Roohangize Nashibi from Ahvaz Jundishapur University of Medical Sciences and other collaborating institutions.

Statistics:

  • 60 COVID-19 patients were included in the study, with 30 healthy individuals as the control group.
  • The researchers observed a 4.5-fold increase in miR200b-3p expression in COVID-19 patients compared to the control group (P < 0.001).
  • IL-6 levels were found to be significantly elevated in COVID-19 patients, with a median value of 36.5 pg/mL in patients compared to 2.5 pg/mL in the control group (P < 0.001).
  • The study found a correlation coefficient of 0.78 between IL-6 levels and miRNA expression profiles (P < 0.01).

Sources:

  • "Elevated Mirna Expression and Il-6 Levels In Covid-19 Patients: Correlations and Implications for Inflammatory Response." Jundishapur Journal of Microbiology, 2025;18(9).
  • NewsRx. Studies from Ahvaz Jundishapur University of Medical Sciences Update Current Data on COVID-19 (Elevated Mirna Expression and Il-6 Levels In Covid-19 Patients: Correlations and Implications for Inflammatory Response). Medical Letter on the CDC & FDA. October 26, 2025; p 407.

Read more